Sio Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-243,035
| Closed | -$5.18M | – | 64 |
|
|
2024
Q1 | $5.18M | Sell |
243,035
-3,001
| -1% | -$35.9K | 1.54% | 22 |
|
|
2023
Q4 | $2.36M | Hold |
246,036
| – | – | 0.54% | 23 |
|
|
2023
Q3 | $640K | Hold |
246,036
| – | – | 0.2% | 42 |
|
|
2023
Q2 | $1.15M | Hold |
246,036
| – | – | 0.29% | 33 |
|
|
2023
Q1 | $928K | Sell |
246,036
-14,412
| -6% | -$56.7K | 0.46% | 32 |
|
|
2022
Q4 | $820K | Hold |
260,448
| – | – | 0.3% | 36 |
|
|
2022
Q3 | $784K | Hold |
260,448
| – | – | 0.25% | 36 |
|
|
2022
Q2 | $649K | Buy |
260,448
+685
| +0.3% | +$3.15K | 0.24% | 46 |
|
|
2022
Q1 | $2.02M | Hold |
259,763
| – | – | 0.67% | 35 |
|
|
2021
Q4 | $1.08M | Hold |
259,763
| – | – | 0.33% | 54 |
|
|
2021
Q3 | $2.06M | Sell |
259,763
-6,344
| -2% | -$53.4K | 0.66% | 42 |
|
|
2021
Q2 | $2.15M | Buy |
266,107
+16,688
| +7% | +$144K | 0.53% | 53 |
|
|
2021
Q1 | $2.67M | Buy |
249,419
+76,726
| +44% | +$897K | 0.54% | 57 |
|
|
2020
Q4 | $2.03M | Buy |
+172,693
| New | +$2.17M | 0.42% | 68 |
|
|
2020
Q3 | – | Sell |
-3,000
| Closed | -$52K | – | 103 |
|
|
2020
Q2 | $52K | Buy |
+3,000
| New | +$52.3K | 0.02% | 78 |
|
Sio Capital Management's FUSN Position: Q2 2024 in Review
Sio Capital Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 243,035 shares — an estimated $5.18M sold.
Sio Capital Management first reported a position in FUSN in Q2 2020 and held it in 15 quarters. The position peaked at $5.18M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.
- Sio Capital Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
- Sio Capital Management sold 243,035 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $5.18M.
- Sio Capital Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 15 quarters.
- Sio Capital Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $5.18M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.
Based on Sio Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.